Literature DB >> 21862477

Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings.

Gemma Croxall1, James Hale, Vivienne Weston, Georgina Manning, Phil Cheetham, Mark Achtman, Alan McNally.   

Abstract

OBJECTIVES: To assess the molecular epidemiology and prevalence of antibiotic resistance in Escherichia coli causing urinary tract infections of elderly patients from community and hospital settings. Also, to determine whether the possession of antibiotic resistance and virulence-associated genes can be linked to patient location or the clonal group of the organisms in question.
METHODS: E. coli were isolated from the urine samples of elderly patients from the Nottingham area, and subjected to antibiotic susceptibility testing, virulence gene detection by PCR and multilocus sequence typing.
RESULTS: No correlation was observed between community- or hospital-derived strains with regard to antibiotic resistance levels or virulence gene profiles. E. coli ST131 (where ST stands for sequence type) was the predominant ST found in both hospital and community samples, and demonstrated high levels of antibiotic resistance to the test panel, but did not possess a significantly larger array of virulence genes or a specific gene profile compared with other STs.
CONCLUSIONS: The level of antibiotic resistance or virulence gene possession in uropathogenic E. coli is not directly associated with the healthcare setting of the patient, but there is a variation in antibiotic resistance and virulence gene possession depending on clonal group. ST131 is highly virulent and demonstrates high levels of antibiotic resistance, but its virulence does not appear to be attributable to the possession of a specific virulence-associated gene set or the possession of any virulence-associated gene in significantly higher levels than in any other ST.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21862477     DOI: 10.1093/jac/dkr349

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  49 in total

Review 1.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

2.  Contribution of Novel Amino Acid Alterations in PmrA or PmrB to Colistin Resistance in mcr-Negative Escherichia coli Clinical Isolates, Including Major Multidrug-Resistant Lineages O25b:H4-ST131-H30Rx and Non-x.

Authors:  Toyotaka Sato; Tsukasa Shiraishi; Yoshiki Hiyama; Hiroyuki Honda; Masaaki Shinagawa; Masaru Usui; Koji Kuronuma; Naoya Masumori; Satoshi Takahashi; Yutaka Tamura; Shin-Ichi Yokota
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

3.  Global Extraintestinal Pathogenic Escherichia coli (ExPEC) Lineages.

Authors:  Amee R Manges; Hyun Min Geum; Alice Guo; Thaddeus J Edens; Chad D Fibke; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2019-06-12       Impact factor: 26.132

4.  Tigecycline Nonsusceptibility Occurs Exclusively in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates, Including the Major Multidrug-Resistant Lineages O25b:H4-ST131-H30R and O1-ST648.

Authors:  Toyotaka Sato; Yuuki Suzuki; Tsukasa Shiraishi; Hiroyuki Honda; Masaaki Shinagawa; Soh Yamamoto; Noriko Ogasawara; Hiroki Takahashi; Satoshi Takahashi; Yutaka Tamura; Shin-Ichi Yokota
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

Review 5.  A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131.

Authors:  Ritu Banerjee; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

6.  Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections.

Authors:  Sheila Adams-Sapper; Binh An Diep; Francoise Perdreau-Remington; Lee W Riley
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

7.  Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans.

Authors:  Aylin Colpan; Brian Johnston; Stephen Porter; Connie Clabots; Ruth Anway; Lao Thao; Michael A Kuskowski; Veronika Tchesnokova; Evgeni V Sokurenko; James R Johnson
Journal:  Clin Infect Dis       Date:  2013-08-06       Impact factor: 9.079

8.  The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics.

Authors:  Ritu Banerjee; Brian Johnston; Christine Lohse; Sujay Chattopadhyay; Veronika Tchesnokova; Evgeni V Sokurenko; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

9.  Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark.

Authors:  Bente Olesen; Dennis S Hansen; Frida Nilsson; Jakob Frimodt-Møller; Rikke Fleron Leihof; Carsten Struve; Flemming Scheutz; Brian Johnston; Karen A Krogfelt; James R Johnson
Journal:  J Clin Microbiol       Date:  2013-04-03       Impact factor: 5.948

10.  Characterization of Escherichia coli isolates from hospital inpatients or outpatients with urinary tract infection.

Authors:  Francisco Toval; Christian-Daniel Köhler; Ulrich Vogel; Florian Wagenlehner; Alexander Mellmann; Angelika Fruth; M Alexander Schmidt; Helge Karch; Martina Bielaszewska; Ulrich Dobrindt
Journal:  J Clin Microbiol       Date:  2013-11-13       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.